HRS2543

· Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS2543, covering 2024-07-18 to 2024-07-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HRS2543 in Patients With Advanced Tumors [Phase 1]